The India Cements (INDIACEM) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
9 Jul, 2026Executive summary
Cement sales exceeded 31 million tons in Q2 FY26, with strong demand for premium cement and rural market growth of 13%.
Domestic sales volume reached 2.44 MnT in Q2 FY26, up 11.9% quarter-over-quarter, with average capacity utilization at 65%.
Brand conversion of acquired UltraTech and Kesoram assets to India Cements is progressing rapidly, with 31% and 55% conversion, respectively, expected to complete by June 2026.
Standalone and consolidated unaudited financial results for the quarter and half-year ended 30 September 2025 were approved, with continued operational focus on cement and related products.
The period saw the approval for sale of the entire equity stake in Industrial Chemicals & Monomers Ltd and the proposed sale of a foreign associate, both classified as held for sale.
Financial highlights
Sales volume grew 22.3% year-over-year (excluding UltraTech and Kesoram from base), 9.6% sequentially, and 6.8% including all assets.
Revenue from operations for Q2 FY26 was ₹1,117 Crores, up from ₹1,007 Crores in Q2 FY25.
Consolidated EBITDA improved to ₹110 Crores from a loss of ₹4 Crores in Q2 FY25.
Standalone revenue from operations for Q2 FY26 was ₹1,117.15 crore, up from ₹1,024.63 crore in Q1 FY26, but net loss for the quarter was ₹6.86 crore, improving from a loss of ₹13.76 crore in Q1.
Operating margins improved to 8.00% standalone and 7.26% consolidated for Q2 FY26.
Outlook and guidance
Brand transition for acquired assets to complete by June 2026, expected to drive further synergy and profitability.
Capex plan of ₹2,000 Crores over the next two years focuses on growth and efficiency improvements.
Green power mix to reach 65% by end of current growth phase, with a target of 80% by FY28.
The company is undergoing restructuring, including the amalgamation of four wholly owned subsidiaries, pending regulatory approvals.
Industry demand growth guidance of 6–7% for the year, with Q2 industry growth at 4.5–5%.
Latest events from The India Cements
- Q1 FY27 delivered double-digit volume growth, record EBITDA, and stable financial health.INDIACEM
Q1 26/2720 Jul 2026 - Double-digit volume growth targeted for FY26, with improved margins and narrowed losses.INDIACEM
Q1 25/268 Jul 2026 - Record capacity, robust growth, higher dividends, and restructuring amid legal and cost headwinds.INDIACEM
Q4 25/2628 Apr 2026 - Sales up 25% YoY, revenue higher, but net losses persist amid cost and legal risks.INDIACEM
Q3 25/2613 Apr 2026 - Profitability returned in Q1 FY25 on an exceptional gain, with major stake sale to UltraTech Cement.INDIACEM
Q1 24/251 Sep 2025 - Losses widened on lower revenue, with major asset sales and a pending UltraTech acquisition.INDIACEM
Q2 24/251 Sep 2025 - Q3 FY25 saw lower revenue, major losses, UltraTech's takeover, and large asset revaluation gains.INDIACEM
Q3 24/251 Sep 2025 - FY25 saw deeper losses, lower revenue, and major legal disputes, with auditors' unmodified opinions.INDIACEM
Q4 24/251 Sep 2025